Data Factory
Reading the graph
Reading the graph
Venture Capital
Cambridge, MA
Delos Capital invests in life science, biotech, and medtech companies transforming bold ideas into medical breakthroughs.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Curatia | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Instylla, Inc. | Ma | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Intrinsic Therapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Rejoni | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| STRM.BIO Therapeutics S e e d | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Truvic | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Ostialflash | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Product type | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Alpha-9 Oncology | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Apbioinc | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Atia | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Ascension Ventures | Delos Advisors, Inc. | 3 | 3 | Sep 17, 2026 | Recurring |
| Ascenta Capital | Delos Advisors, Inc. | 1 | 1 | Sep 16, 2026 | One time |
| Chv | Delos Advisors, Inc. | 1 | 1 | Sep 16, 2026 | One time |
| Femhealth Ventures Management LLC | Delos Advisors, Inc. | 1 | 1 | Sep 16, 2026 | One time |
| KDT Ventures | Delos Advisors, Inc. | 1 | 1 | Sep 16, 2026 | One time |
| Lightspeed Venture Partners | Delos Advisors, Inc. | 1 | 1 | Sep 17, 2026 | One time |
| Questa Capital Management, L.L.C. | Delos Advisors, Inc. | 1 | 1 | Sep 16, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Carrie Greenaway (Office Manager), Andrea Lok (Executive Assistant), Henry Chen (Founder & Managing Partner), Eric Huang (Partner), Tej Pavoor (Partner), Tim Xiao (Partner), Yang Cheng (Associate), Lee Cooper (Managing Director), Wynne Chan (Office Manager), Agnes Kwok (Financial Controller), Paul Shen (Operations Manager), Ban Ling Kwok (Cco & Financialcontroller Of Delos Advisors, Inc.).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan